uring laparoscopic surgery, a large amount of gas, generally carbon dioxide (CO 2 ), is introduced into the peritoneal cavity. The CO 2 absorption from the peritoneal surface results in hypercapnia and acidosis during the pneumoperitoneum induced by intraperitoneal CO 2 insufflation. 1 The limitation of diaphragm movements, secondary to pneumoperitoneum, leads to a reduction in the functional residual capacity (FRC) and pulmonary compliance. Obese patients are particularly affected by this condition, more than non-obese patients. 2 Some studies showed that continuous positive airway pressure (CPAP) was effective on oxygenation after laparascopic cholecystectomy surgery. 3, 4 However, studies investigating the effects of postoperative CPAP on blood gases in laparoscopic cholecystectomy surgery performed in obese patients are lacking. We hypothesized that postoperative CPAP would be more effective than nasal oxygen use on blood gasses in obese patients.
MATERIAL AND METHOD
A total of 40 patients aged between 18 and 65 years, with American Society for Anesthesiology status I and II, a body mass index (BMI) in the range of 30-40 and who were scheduled to undergo elective laparoscopic cholecystectomy were included in the trial after the approval of the Selçuk University Meram Medical Faculty Ethical Committee (June 26, 2009. 2009/348) . All patients signed an informed consent form in accordance with the Helsinki Declaration. Patients with ischemic cardiac disease, congestive cardiac failure, liver or kidney dysfunction, respiratory disorder, psychiatric conditions and cooperation failures, and known hypersensitivity to the study medications were excluded.
On admission to the operating room, 0.9% sodium chloride infusion was initiated after peripheral vascular access was provided using an 18-gauge cannula. The patients were randomly assigned to two groups [Group C (n:20)= continuous positive airway pressure (CPAP), Group N (n:20)= Nasal O 2 ] and were given the Allen's test via the closed envelope method. After this, a 20G cannula was placed in the radial artery of the nondominant arm under local anesthesia (20 mg %2 lidocaine) with sedation (midazolam 1 mg iv). Baseline blood gas was sampled on spontaneous respiration (G 0 ) for analysis. The blood gas sample was assayed using a blood gas device (Rapidlap ® Healtcare-Bayer) in the operating room immediately after blood sample was drawn. The heart beat rate (HR), the mean arterial pressure (MAP) For induction of anesthesia, all the patients received 2 mg/kg iv bolus propofol (Propofol ® Fresenius Kabi-Sweden) and 1 µg/kg remifentanil (Ultiva™ GlaxoSmithKline-Italy) as a 60-second intravenous bolus (iv) administration. 5 After achieving loss of consciousness, endotracheal intubation was performed following 3 minutes after atracurium (Tracrium ® GlaxoSmithKline) administration. 6 The drugs used in anaesthesia were calculated based on total body weight (TBW). Trachea was intubated by 9.0 (for males) or 8.0 (for females) mm diameter (ID) endotracheal tube. To prevent vomiting, 4 mg ondansetron was administered to all patients before the induction of anesthesia.
Ventilation was provided by using a mechanical ventilator (Drager Primus-Germany) at a tidal volume of 6-8 mL/kg (total body weight) and a respiratory rate of 10-14/min to achieve an EtCO 2 of 35±5 mmHg. 7 The maintenance of anesthesia was provided by 50/50% oxygen/air and 0.5 minimum alveolar concentration (MAC) sevofluran (Sevoflurane ® Abbott-UK) and 0.25 µg/kg/min remifentanil infusion. 8 Pneumoperitoneum was kept constant at 12 cm H 2 O pressure. Tramadol (Contramal ® -Abdi İbrahim) was administered as an IV infusion, at a dose of 1 mg/kg, 30 minutes before the end of the surgery to achieve postoperative analgesia. Sevofluran and remifentanil infusion Turkiye Klinikleri J Med Sci 2012;32 (3) was terminated five minutes before the end of the surgery and the patients inhaled 100% oxygen. Upon initiation of spontaneous respiration, 0.04-0.08 mg/kg neostigmine (Neostigmine ® AdekaTurkey) and 0.02-0.04 mg/kg atropine were administered, thereby eliminating the muscle relaxant effect. After extubation, blood gas samples were obtained (G 1 ) and the patients were admitted to the PACU. CPAP was administered using the Drager Evita XL -Germany device by oronasal mask to achieve CPAP 5 cmH 2 O, FiO 2 0.35 in Group C, while 4 l/min (FiO 2 0.31-0.38) O 2 was administered for 60 minutes via nasal cannula in Group N. Blood gas sampling was performed after 60 minutes in both groups (G 2 ). At the PACU, SpO 2 values were recorded every 10 minutes.
All the adverse effects (nausea, vomiting, CPAP incompliance, pain) and additional medications were recorded for all patients. Nausea was assessed on a 5-point scale (0: no 1: mild nausea, 2: moderate nausea, 3: severe nausea, 4: retching and vomiting). A 10 mg intravenous metoclopramide administration was planned for cases with a nausea-vomiting score ≥2. The pain was assessed with visual analogue scale (VAS) using a 10-cm line scale (0: no pain, 10=unbearable pain) before admitting to and after discharging from the PACU of the patient.
STATISTICAL ANALYSIS
Data obtained were analyzed by the SPSS 13.0 program. In this study including two groups and three recurrent measurements, a power analysis indicated that 95% confidence for 20 subjects in each group would be required to achieve a statistical power of 0.84 based on the standardized effect size of 0.5. Data were summarized using the frequency, arithmetic mean and ±standard deviation. A comparison of the distribution of the categorical data to the CPAP and nasal O 2 groups was performed using the "chi-square (χ 2 ) test". Sample means were tested for normality using the Kolmogorov -Simirnov test. To compare the values from the CPAP and the nasal O 2 groups of the analyzed variables, the independent Student's t test was used. A Two-way ANOVA test was used to compare the variables presented in repeated measurements with respect to the groups and time; the Student's t-test was used in independent groups with Bonferroni correction. The difference was considered statistically significant at p<0.05 (p<0.01 on Bonferroni correction) for all analyses.
RESULTS
The 40 patients included in the trial showed similarity in the demographic characteristics, anesthesia and duration of surgery (Table 1 ) (p>0.05). There was no significant difference between the two groups in the intraoperative EtCO 2 measurements (P>0.05) (Figure 1) . At the PACU, the SpO 2 values at 30 minutes were significantly higher in Group C relative to Group N (p<0.05) (Figure 2 ). The comparison of the pH values in the blood gas samples at G 0 , G 1 and G 2 revealed no significant difference in either group (P>0.05). The comparison of the intra group pH values revealed significantly lower values for G 1 compared to G 0 for both groups (p<0.01) ( Table 2) . While there was no significant difference between the PaCO 2 values on blood gas samples between the two measurement times, G 0 and G 1 , the PaCO 2 value was significantly higher at G 2 in Group N relative to Group C (p<0.05). The in-group comparison of the PaCO 2 values at G 0 and G 1 revealed a statistically significant difference (p<0.01). The G 1 PaCO 2 values of Group C and Group N were higher than the G 0 values (Table 3 ). The finding that the PaO 2 value in the blood gas sample at G 2 in Group C was higher than that in Group N had statistical significance (p<0.05) ( Table 4 ). The two groups showed similarity in nausea-vomiting rates (p>0.05) ( Table 5 ). Metoclopramide 10 mg IV was administered to three patients in Group C and two patients in Group N due to a nausea-vomiting score ≥2. The pain score was similar between the two groups (p>0.05) ( Table 6 ). Two patients were incompatible with CPAP.
DISCUSSION
The effects of CPAP and nasal oxygen use were compared on postoperative blood gases in obese patients undergoing laparoscopic cholecystectomy. Postoperative CPAP use increased the PaO 2 more and provided a better CO 2 elimination compared to nasal oxygen use.
Respiratory complications occurring after surgery represent the leading cause of prolonged hospitalization due to an increase in morbidity and mortality. The most significant risk factor affecting postoperative respiratory functions is obesity. Trials reported a respiratory complication incidence of 9-69% following non-thoracic surgery. 9 Most of the respiratory complications result from changes in the pulmonary volume secondary to disorder of the chest wall mechanics and dysfunction of the respiratory muscles. Following abdominal and thoracic surgery, a marked reduction in vital capacity and a less marked reduction in functional residual capacity occur. The CO 2 insufflated during laparoscopic surgery is rapidly absorbed from the peritoneal cavity, thereby resulting in hypercapnia and acidosis. 10, 11 Another factor involved in the occurrence of complications is the increase in Closure Volume (CV). If CV, accounting for 30% of the total lung capacity, increases to the point where it exceeds FRC, some of the alveoli which are normally required to remain open are closed, thus leading to decreased ventilation and atelectasia. 9 Berström et al induced pneumoperitoneum in laparoscopic surgery in pigs with CO 2 in one group and with helium in another group; the comparison of the pH values between the two groups revealed a lower value in the CO 2 group compared to the helium group. 12 A trial by Iwasaka et al including patients receiving laparoscopic cholecystectomy reported an increase in PaCO 2 and EtCO 2 during the CO 2 insufflation and a secondary reduction in the pH value. 1 Reviewing the impact of the CO 2 pneumoperitoneum induced for laparoscopic surgery on the postoperative blood gas in our trial, a significant reduction was observed in both groups following laparoscopy in line with the results from the previous trials. The PaCO 2 value was higher than the control values. The absence of a significant change in the EtCO 2 value was attributed to the fact that the ventilator setting was corrected to EtCO 2 35±5.
Obese patients have a higher requirement for postoperative respiratory support. 13 The methods commonly used to prevent pulmonary complica-
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Group N (n=20) p tions include respiratory physiotherapy, pulmonary expansion techniques, oxygen administration via nasal route or by mask, and non-invasive mechanical ventilation (NIMV). [14] [15] [16] Ayhan et al monitored the oxygen administered via postoperative nasal cannula and mask by using a pulse oximeter and demonstrated that the patients' BMI and ASA class were involved in the low saturation observed and that nasal oxygen application was more effective than the mask application. 17 Gift et al. suggested that postoperative nasal oxygen application was more convenient and effective relative to mask application. 18 Nasal intermittent mandatory ventilation (NIMV) is a method used to provide positive-pressure respiratory support by mask without using an endotracheal tube. Recently, the use of NIVM in cases of chronic obstructive pulmonary disease (COPD), cardiogenic pulmonary edema, extubation or postoperative respiratory failure has gradually increased. 19 NIMV is designed to correct ventilation to relax the respiratory muscles, thereby correcting hypercapnia and secondary acidosis. 20 NIMV is being used increasingly in the care of patients suffering acute respiratory failure. Highlevel evidence supports the use of NIMV to treat COPD exacerbations. NIMV has also been successfully used in selected patients suffering acute hypoxemic respiratory failure. 21 Although both masks performed similarly with regard to improving vital signs and gas exchange and avoiding intubation, the nasal mask was less well tolerated than the oronasal mask in patients with acute respiratory failure. 22 A meta-analysis by Ferreyra et al. suggested that CPAP decreased the postoperative pulmonary complications, and recommended its use in the treatment of post-abdominal-surgery respiratory complications. 23 In a trial by Ursavas et al investigating the factors affecting the success of NIMV in patients with acute hypercapnic respiratory failure, the improvement in PaCO 2 and pH was detected to be a good predictor for success or failure. 24 Our results showed no difference between the two groups in pH values based on the comparison of the blood gas values. The CPAP group had a lower PaCO 2 value compared to the nasal oxygen group.
In addition, Group C had a higher PaO 2 value relative to that in Group N.
In a trial by Meng et al. investigating the impact of CPAP following a laparoscopic gastric bypass operation on postoperative nausea-vomiting, no significant difference was detected between the groups receiving and not receiving CPAP. 25 In our trial, we also could not detect any difference between the two groups in nausea and vomiting based on the assessment of postoperative nausea and vomiting. Two patients, incompatible with CPAP were excluded from the study. Smith RA et al showed in their study that CPAP use by an external mask (mask or nasal CPAP) has been increasing for the treatment of patients with severe hypoxaemia who have adequate carbon dioxide elimination. Good candidate for mask or nasal CPAP are patients with severe hypoxaemia requiring more than 80% oxygen to achieve PaO 2 above 60 mmHg. They must have a normal PaCO 2 , not have severe respiratory distress and be awake and alert. 26 Bolus dose recommendations are generally based on total body weight (TBW), a valid approach for non-obese subjects of varying sizes. However, in morbidly obese subjects, the increase in lean body weight (LBW) is not proportional to the increase in adipose tissue. 27 The volume of fat tissue increases proportionally with TBW and BMI. The absolute value of LBW increases in morbidly obese subjects; however, the percentage of lean body tissue relative to TBW actually decreases. In addition, increased CO and stroke volume are proportionately greater in the individual whose increased size is due to increased lean tissue rather than adipose tissue. 28 Because these changes in body composition and distribution of blood flow alter a drug's distribution, obese patients need doses individualized according to other dosing scalars. 29 One of the limitations of this study is that the drugs used for anesthesia were based on TBW.
Postoperative CPAP application can increase the PaO 2 more and provide a better CO 2 elimination compared to the nasal oxygen application in obese patients undergoing laparoscopic cholecystectomy.
